Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Company Info
Contact US
Hemab Therapeutics
Preclinical CRO / Technology
Overview
Contact US
Contributions
Contributors
Contributions
Sign in
1 Contributions
1 / 1
1 / 1
0 Contributors
1 / 0
1 / 0
No authors found
Annual Congress
Hemab Shares Phase 2 HMB-001 Data for Glanzmann Thrombasthenia & HMB-002 Preclinical Data for Von Willebrand at EAHAD 2025
Hemab Therapeutics
PR-01-25-NI-35
Feb 07, 2025
